Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nyxoah Ord Shs NYXH

Healthcare Medical Devices
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every... see more

Recent & Breaking News (NDAQ:NYXH)

Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results

GlobeNewswire August 8, 2023

Publication Relating to a Transparency Notification

GlobeNewswire July 27, 2023

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference

GlobeNewswire July 27, 2023

Information on the Total Number of Voting Rights and Shares

GlobeNewswire July 27, 2023

Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023

GlobeNewswire July 27, 2023

Nyxoah Reports First Quarter 2023 Financial and Operating Results

GlobeNewswire May 16, 2023

Invitation to Attend the Annual Shareholders' Meeting of the Company to be Held on June 14, 2023

GlobeNewswire May 12, 2023

Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer

GlobeNewswire May 10, 2023

Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023

GlobeNewswire May 1, 2023

Publication Relating to Transparency Notifications

GlobeNewswire April 20, 2023

Information on the Total Number of Voting Rights and Shares

GlobeNewswire April 17, 2023

Nyxoah Raises $3 Million from its At-the-Market Equity Offering

GlobeNewswire April 13, 2023

Information on the Total Number of Voting Rights and Shares

GlobeNewswire March 31, 2023

Nyxoah Raises $3 Million from an At-the-Market Equity Offering

GlobeNewswire March 27, 2023

Nyxoah Announces a $15 Million Private Placement Financing

GlobeNewswire March 23, 2023

Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

GlobeNewswire March 22, 2023

Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023

GlobeNewswire March 8, 2023

Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference

GlobeNewswire March 7, 2023

Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones

GlobeNewswire March 6, 2023

Nyxoah Announces Inaugural Investor & Analyst Meeting

GlobeNewswire February 22, 2023